Web-based therapy for depression
The Efficacy and Treatment Mechanisms of the Web-based Acceptance and Commitment Therapy for Patients with Major Depressive Disorder
NA · Gachon University · NCT06293781
This study is testing if online therapy called Acceptance and Commitment Therapy can help people with depression feel better by looking at how it affects their thinking and brain activity.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 19 Years to 65 Years |
| Sex | All |
| Sponsor | Gachon University (other) |
| Locations | 1 site (Incheon, Please Incheon) |
| Trial ID | NCT06293781 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of web-based Acceptance and Commitment Therapy (ACT) for individuals diagnosed with Major Depressive Disorder. It is a randomized controlled trial that aims to assess changes in psychological flexibility and cognitive fusion among participants. Additionally, the study will utilize functional MRI to explore the underlying mechanisms of how web-based ACT may facilitate recovery from depression.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Major Depressive Disorder.
Not a fit: Patients with serious medical issues, severe brain injuries, or those at high risk for suicide may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide an accessible and effective treatment option for individuals suffering from depression.
How similar studies have performed: Other studies have shown promise in using web-based therapies for mental health conditions, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who diagnosed major depressive disorder Exclusion Criteria: * Patients who have serious medical problems, metal implants in their bodies, severe brain injury or brain disease * Women who were pregnant or nursing * Patients at high risk for suicide
Where this trial is running
Incheon, Please Incheon
- Kyoung-Sae Na — Incheon, Please Incheon, Korea, Republic of (RECRUITING)
Study contacts
- Study coordinator: Kyoung-Sae Na, MD, PhD
- Email: ksna13@gmail.com
- Phone: 82324689932
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Major Depressive Disorder